Flap over $311,000 Vertex drug in Arkansas highlights growing drug-cost strain

The state of Arkansas' Medicaid program will likely change its guidelines restricting use of the cystic-fibrosis drug made by Vertex Pharmaceuticals on the basis of cost, the latest case highlighting the tension between pharmaceutical companies and health care payers over medication pricing...